126 related articles for article (PubMed ID: 7510585)
21. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
22. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
23. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.
Okochi H; Kato M; Nashiro K; Yoshie O; Miyazono K; Furue M
Br J Dermatol; 1997 Dec; 137(6):856-63. PubMed ID: 9470900
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
25. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
[TBL] [Abstract][Full Text] [Related]
26. Gene structure, chromosomal localization, and protein sequence of mouse CD53 (Cd53): evidence that the transmembrane 4 superfamily arose by gene duplication.
Wright MD; Rochelle JM; Tomlinson MG; Seldin MF; Williams AF
Int Immunol; 1993 Feb; 5(2):209-16. PubMed ID: 8452817
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of CD82 in the early phase of T cell activation: roles in cell adhesion and signal transduction.
Shibagaki N; Hanada K; Yamaguchi S; Yamashita H; Shimada S; Hamada H
Eur J Immunol; 1998 Apr; 28(4):1125-33. PubMed ID: 9565351
[TBL] [Abstract][Full Text] [Related]
28. The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1.
Korínek V; Stefanová I; Angelisová P; Hilgert I; Horejsí V
Immunogenetics; 1991; 33(2):108-12. PubMed ID: 1999350
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of CD82 on human T cells enhances LFA-1 / ICAM-1-mediated cell-cell adhesion: functional association between CD82 and LFA-1 in T cell activation.
Shibagaki N; Hanada Ki; Yamashita H; Shimada S; Hamada H
Eur J Immunol; 1999 Dec; 29(12):4081-91. PubMed ID: 10602019
[TBL] [Abstract][Full Text] [Related]
30. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48.
Yokoyama S; Staunton D; Fisher R; Amiot M; Fortin JJ; Thorley-Lawson DA
J Immunol; 1991 Apr; 146(7):2192-200. PubMed ID: 1848579
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
Sidorenko SP; Clark EA
J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
[TBL] [Abstract][Full Text] [Related]
32. Functional effects of a monoclonal antibody directed against a distinct epitope on 4F2 molecular complex in human peripheral blood mononuclear cell activation.
Spagnoli GC; Ausiello C; Palma C; Bellone G; Ippoliti G; Letarte M; Malavasi F
Cell Immunol; 1991 Aug; 136(1):208-18. PubMed ID: 1711930
[TBL] [Abstract][Full Text] [Related]
33. A new epitope of the T200 molecule family defined by the 3A35 monoclonal antibody and expressed by macrophages and activated T lymphocytes.
Le Corre R; Gerlier D; Martin A; Le Garrec Y; Corradin G; Bron C; Toujas L
Eur J Immunol; 1987 Mar; 17(3):327-33. PubMed ID: 2436920
[TBL] [Abstract][Full Text] [Related]
34. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells.
Imai T; Yoshie O
J Immunol; 1993 Dec; 151(11):6470-81. PubMed ID: 8245480
[TBL] [Abstract][Full Text] [Related]
35. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
[TBL] [Abstract][Full Text] [Related]
37. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
39. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation.
Geppert TD; Lipsky PE
J Immunol; 1991 May; 146(10):3298-305. PubMed ID: 1673981
[TBL] [Abstract][Full Text] [Related]
40. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
Ballas ZK; Rasmussen W
J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
